Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
boston top stories
ipo
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
venture capital
2
×
2025
ad-comm
affimed
akcea therapeutics
allogene therapeutics
amgen
amicus therapeutics
approval
apremilast
base editing
bio
biogen
biome
blueprint medicineas
boulder/denver blog main
boulder/denver top stories
briefing docs
cancer
cancer drugs
car-t
celgene
cervical cancer
clinical study
clinical trial
clinical trials
cobimetinib
commissioner
crispr
crispr therapeutics
cybersecurity
What
cancer
2
×
ipo
allogene
bio
crispr
despite
diversity
drug
family
hardest
hit
hot
hottest
hunters
immunotherapy
investors
juno
medicines
million
nearly
new
proteins
ras
reels
remains
research
revolution
roundup
shares
snapped
targets
therapeutics
ticket
utero
years
Language
unset
Current search:
cancer
×
" venture capital "
×
biotech
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More